Related Experiment Video
Updated: May 24, 2026
08:19
Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
Published on: July 7, 2020
Resistance to antimicrobial peptides in Gram-negative bacteria
Samantha Gruenheid1, Hervé Le Moual
1Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada.
FEMS Microbiology Letters
|February 21, 2012
Summary
Antimicrobial peptides (AMPs) are crucial for innate immunity, defending against pathogens. Gram-negative bacteria have evolved sophisticated mechanisms to sense and resist these peptides, impacting infection and therapeutic strategies.
Area of Science:
- Immunology
- Microbiology
- Biochemistry
Background:
- Antimicrobial peptides (AMPs) are vital components of the innate immune system across organisms.
- Found on body surfaces and in secretions, AMPs provide a first line of defense against diverse pathogens.
- AMPs exhibit microbicidal activity and modulate immune responses through chemoattractant and signaling functions.
Purpose of the Study:
- To review the mechanisms employed by Gram-negative bacteria to sense and resist AMP-mediated killing.
- To highlight the significance of these bacterial resistance strategies in the context of host-pathogen interactions.
- To underscore the importance of considering bacterial resistance in the development of AMP-based anti-infective agents.
Main Methods:
- Literature review focusing on Gram-negative bacterial resistance mechanisms against AMPs.
- Analysis of co-evolutionary strategies between hosts and bacterial pathogens regarding AMPs.
- Synthesis of current understanding of AMPs' role in innate immunity and bacterial pathogenesis.
Main Results:
- Gram-negative bacteria possess adaptive responses to detect and counteract AMPs.
- These sensing and resistance mechanisms are critical for bacterial survival during host infections.
- Bacterial resistance to AMPs is a significant factor influencing the efficacy of AMP-based therapies.
Conclusions:
- Bacterial resistance to AMPs is a well-established phenomenon driven by evolutionary pressure.
- Understanding these resistance mechanisms is essential for combating infections involving AMP-resistant bacteria.
- Future development of AMP therapeutics must account for and potentially overcome bacterial resistance strategies.
Related Concept Videos
01:23Antimicrobial Proteins
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:23Inhibitors of Gram-positive Cell Wall Synthesis
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:28Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...